Search
for
Sort by
Research 30 of 1000+
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Journal of Population Therapeutics and Clinical Pharmacology
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Gestational Thyroid Dysfunction in a Sub-District Area of Pampore, Kashmir: A Cross-Sectional Study
- Complete responses and SALT zero scores in alopecia areata: not the same
- Using qualitative methods to establish the clinically meaningful threshold for treatment success for the Severity of Alopecia Tool (SALT) score
- Preparation and application of tea-seed saponin modified silicone polymer quaternary ammonium salt
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Intralesional Methotrexate Is Comparable to Triamicinolone Acetonide and Superior to Vitamin D3 in the Treatment of Alopecia Areata
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Janus Kinase Inhibitors for Alopecia Areata
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- Long-term Efficacy and Safety of Upadacitinib in the Treatment of Alopecia Areata: A Retrospective Study
- Clinical, Biochemical and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority